"Philips Faces Setbacks and Progress in CPAP Machine Recall and Rebuilding Efforts"

Philips Respironics will stop U.S. sales of its ventilators and CPAP breathing machines after reaching a settlement with the FDA, following a recall of over 1 million machines in 2021 due to reports of blowing gas and foam into users’ airways. The company will continue servicing existing machines but halt new sales until certain conditions are met, with a settlement amount yet to be determined. The sales halt affects widely used CPAP and BiPAP machines, and the company has apologized for the harm caused to patients, while the FDA remains unsatisfied with the recall's status as of October.